Abstract

Ubiquitin and ubiquitin-like proteins (Ubls) are signalling messengers that control many cellular functions, such as cell proliferation, apoptosis, the cell cycle and DNA repair. It is becoming apparent that the deregulation of ubiquitin pathways results in the development of human diseases, including many types of tumours. Here we summarize the common principles and specific features of ubiquitin and Ubls in the regulation of cancer-relevant pathways, and discuss new strategies to target ubiquitin signalling in drug discovery.

Author affiliations

1. Institute of Biochemistry II, Goethe University School of Medicine, University Hospital, Building 75, Theodour-Stern-Kai 7, D-60590 Frankfurt, Germany.
2. Mediterranean Institute for Life Sciences, Mestrovicevo Setaliste bb, 21 000 Split, Croatia.

Correspondence to: Ivan Dikic² Email: ivan.dikic@biochem2.de

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.